Share
Glaucoma Australia will award $200,000 in the first round of its new Glaucoma Research Grants Program funded by the William A Quinlivan Research Fund. Applications are now open until 1 September 2019, with the successful recipients being announced on World Sight Day (10 October 2019).
“Glaucoma Australia research grants have made significant contributions to Australian medical and social research into glaucoma. We are now very proud to be launching our new Research Grants Program which will continue to fund research that supports our mission to eliminate glaucoma blindness” said Glaucoma Australia CEO Annie Gibbins.
The William A Quinlivan Research Fund was established in 2006 and now has over $1.8M in assets. Since its inception, Glaucoma Australia has committed $934,527.00 to support Australian glaucoma researchers across a diverse range of projects.
“Over the years the William A Quinlivan Research Fund has supported over 30 productive research projects and provided more than a dozen scholarships for researchers. We now seek to expand the fund substantially to meet the goals and wishes of our members and create a more positive future for persons with glaucoma’ Ms Gibbins added.
“Glaucoma Australia is committed to funding and supporting high quality glaucoma research in Australia. The broad aims of research we support are to improve the lives of people with glaucoma through better glaucoma detection and treatment. We are excited to facilitate the innovative research of academics who drive progress in glaucoma management” said Glaucoma Australia Research Committee Chair, Dr Simon Skalicky.
Glaucoma Australia will commit $200,000 in the first round of its new program, and anticipates that individual grants of $50,000 - $100,000 per annum will be awarded for projects up to 3 years in duration. Seed fund grants could be used to apply for further funding with NHMRC or other agencies.
The first round of grants for research commencing in 2020 is now open. Applications will be accepted from 1 July until 1 September 2019.
Funding research into improving glaucoma detection, treatment and improving lives for people with glaucoma is integral to Glaucoma Australia's mission to eliminate glaucoma blindness. You can contribute to this research by making a tax deductible donation online www.glaucoma.org.au/donation or text SIGHT to 0400 662 662.
For more information
Annie Gibbins
CEO glaucoma Australia
(02) 9411 7722
ceo@glaucoma.org.au
Research suggests a large language model (LLM) artificial intelligence (AI) system can match, or sometimes do better than, human eye doctors in diagnosing and treating patients with glaucoma and retina disease.
Glaucoma Australia is thrilled to welcome Senior Orthoptist Patient Educator Val Tosswill to provide comprehensive support to patients enrolled in its SiGHTWiSE Patient Support Program.
Funding research to enhance glaucoma detection, treatment, and the lives of individuals with glaucoma is fundamental to Glaucoma Australia's mission to prevent glaucoma blindness.